ARCHIVES

In Brief: James Downing named CEO of St. Jude

This article is from The Cancer Letter archive.

Vol. 40 No. 26 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approves Evista for Breast Cancer Risk Reduction.

September 14, 2007

Cancer Genetics Network approved By NCI Advisors, To Start With 8 Centers

November 29, 1996

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

July 25, 1975

ACS To Accept Database On Method Of Unconventional Rx

November 26, 1993

Cooperative Group-cancer control Program To Continue

August 10, 1979

In Brief: NCI To Push “Cancer Prevention Awareness” This Month; Three RFPs Delayed For Changes

February 17, 1984